PlasmaSource, LLC – Trademark Portfolio

Entity Type: 16

PlasmaSource, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PLASMASOURCE and GIVE LIFE. GET PAID.. The owner is based in Scottsdale, AZ.

9305 East Via de Ventura

Scottsdale, AZ 85258

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PlasmaSource, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does PlasmaSource, LLC have?

PlasmaSource, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does PlasmaSource, LLC file in?

PlasmaSource, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are PlasmaSource, LLC's most well-known trademarks?

PlasmaSource, LLC's registered trademark portfolio includes well-known marks such as PLASMASOURCE and GIVE LIFE. GET PAID.. These are among 2 currently registered trademarks in the portfolio.

What is PlasmaSource, LLC's trademark registration success rate?

PlasmaSource, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.